Increased incidence of CYP2D6 gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of nonresponse. A pilot study

This publication has 23 references indexed in Scilit:

• A patient with treatment-resistant schizophrenia and cytochrome P4502D6 gene duplication
  Clinical Genetics, 2002
• Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs
  British Journal of Clinical Pharmacology, 2002
• Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype.
  1999
• Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation
  British Journal of Clinical Pharmacology, 1999
• Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes
  Gene, 1999
• PCR-based genotyping for duplicated and deleted CYP2D6 genes
  Pharmacogenetics, 1996
• Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
  1996
• Outcome of Depression in Psychiatric Settings
  The British Journal of Psychiatry, 1994
• Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine
  The Lancet, 1993
• Development of a Rating Scale for Primary Depressive Illness
  British Journal of Social and Clinical Psychology, 1967